Sodium glucose Co-transporter 2 (SGLT2) inhibitors are second line dual therapy. They can cause diabetic ketoacidosis. A high index of suspicion is needed for diagnosis.
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.